Epidermolysis bullosa acquisita

Medicine and Dentistry

• Epidermolysis Bullosa Acquisita 91%
• Autoantibody 16%
• Corticosteroid 16%
• Collagen Type 7 16%
• Bullous Disease 16%
• Therapeutic Procedure 16%
• Clinical Feature 8%
• Systemic Therapy 8%
• Immunoglobulin 8%
• Colchicine 8%
• Injury 8%
• Rituximab 8%
• Dapsone 8%
• Skin Fragility 8%
• Anchoring Fibrils 8%
• Epidermolysis Bullosa Dystrophica 8%
• Blister 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Epidermolysis Bullosa Acquisita 91%
• Autoantibody 16%
• Corticosteroid 16%
• Collagen Type 7 16%
• Mouse Model 8%
• Colchicine 8%
• Immunoglobulin 8%
• Rituximab 8%
• Dapsone 8%
• Clinical Feature 8%
• Injury 8%
• Blister 8%
• Skin Fragility 8%
• Epidermolysis Bullosa Dystrophica 8%

Biochemistry, Genetics and Molecular Biology

• Epidermolysis bullosa 100%
• Corticosteroid 16%
• Autoantibody 16%
• Collagen 16%
• Mouse Model 8%
• Intravenous Immunoglobulin 8%
• Rituximab 8%
• Anchoring Fibrils 8%
• Genetics 8%
• Dapsone 8%